Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Clinical trial NCT03017690 · COMPLETED
Trial details
- NCT number
- NCT03017690
- Sponsor
- Ipsen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-12
- Primary completion
- 2018-05-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.